Chronic kidney disease, cognitive decline, and incident dementia: The 3C Study

Neurology

Volumn 77, Issue 23, 2011, Pages 2043-2051

  Helmer, Catherine ^a   Stengel, B ^b   Metzger, M ^b   Froissart, M ^b   Massy, Z A ^a,c   Tzourio, C ^a,d,e   Berr, C ^a   Dartigues, J F ^a  

^a INSERM   (France)

^b CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^c Divisions of Clinical   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

^e UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; HYPOCHOLESTEROLEMIC AGENT;

AGED; ALZHEIMER DISEASE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN BLOOD VESSEL; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GROUPS BY AGE; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; KIDNEY FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; MULTIINFARCT DEMENTIA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SCREENING TEST;

EID: 82955225243     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31823b4765     Document Type: Article

References (40)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronickidney disease in the United States. JAMA 2007;298:2038-2047. (Pubitemid 350074801)
2. Ferri CP, Prince M, Brayne C, et al. Global prevalence ofdementia: A Delphi consensus study. Lancet 2005;366:2112-2117. (Pubitemid 41797645)
3. Kurella M, Chertow GM, Luan J, Yaffe K. Cognitive impairmentin chronic kidney disease. J Am Geriatr Soc2004;52:1863-1869. (Pubitemid 41710270)
4. Murray AM, Tupper DE, Knopman DS, et al. Cognitiveimpairment in hemodialysis patients is common. Neurology2006;67:216-223.
5. Elias MF, Elias PK, Seliger SL, Narsipur SS, Dore GA,Robbins MA. Chronic kidney disease, creatinine and cognitivefunctioning. Nephrol Dial Transplant 2009;24:2446-2452.
6. Kurella M, Yaffe K, Shlipak MG, Wenger NK, ChertowGM. Chronic kidney disease and cognitive impairment inmenopausal women. Am J Kidney Dis 2005;45:66-76. (Pubitemid 40038046)
7. Kurella Tamura M, Wadley V, Yaffe K, et al. Kidneyfunction and cognitive impairment in US adults: TheReasons for Geographic and Racial Differences in Stroke(REGARDS) Study. Am J Kidney Dis 2008;52:227-234. (Pubitemid 351978145)
8. Tsai CF, Wang SJ, Fuh JL. Moderate chronic kidney diseaseis associated with reduced cognitive performance inmidlife women. Kidney Int 2010;78:605-610.
9. Weiner DE. The cognition-kidney disease connection: Lessonsfrom population-based studies in the United States.Am J Kidney Dis 2008;52:201-204. (Pubitemid 351978148)
10. Knopman DS. Invited commentary: Albuminuria and microvasculardisease of the brain: A shared pathophysiology. Am JEpidemiol 2010;171:287-289; author reply 290-281.
11. Murray AM. The brain and the kidney connection: Amodel of accelerated vascular cognitive impairment. Neurology2009;73:916-917.
12. Buchman AS, Tanne D, Boyle PA, Shah RC, Leurgans SE,Bennett DA. Kidney function is associated with the rate ofcognitive decline in the elderly. Neurology 2009;73:920-927.
13. Etgen T, Sander D, Chonchol M, et al. Chronic kidneydisease is associated with incident cognitive impairment inthe elderly: The INVADE study. Nephrol Dial Transplant2009;24:3144-3150.
14. Kurella M, Chertow GM, Fried LF, et al. Chronic kidneydisease and cognitive impairment in the elderly: The health,aging, and body composition study. J Am Soc Nephrol2005;16:2127-2133. (Pubitemid 41716444)
15. Slinin Y, Paudel ML, Ishani A, et al. Kidney function andcognitive performance and decline in older men. J AmGeriatr Soc 2008;56:2082-2088.
16. Jassal SK, Kritz-Silverstein D, Barrett-Connor E. A prospectivestudy of albuminuria and cognitive function inolder adults: The Rancho Bernardo study. Am J Epidemiol2010;171:277-286.
17. Barzilay JI, Fitzpatrick AL, Luchsinger J, et al. Albuminuriaand dementia in the elderly: A community study. Am JKidney Dis 2008;52:216-226. (Pubitemid 351982029)
18. Seliger SL, Siscovick DS, Stehman-Breen CO, et al. Moderaterenal impairment and risk of dementia among olderadults: The Cardiovascular Health Cognition Study. J AmSoc Nephrol 2004;15:1904-1911. (Pubitemid 38822071)
19. Sundelof J, Arnlov J, Ingelsson E, et al. Serum cystatin Cand the risk of Alzheimer disease in elderly men. Neurology2008;71:1072-1079.
20. 3C Study Group. Vascular factors and risk of dementia:design of the Three-City Study and baseline characteristicsof the study population. Neuroepidemiology 2003;22:316-325.
21. The Three-City Study: Bordeaux, Dijon, Montpellier.Available at: Http://www.three-city-study.com/. AccessedMarch 2010.
22. Breton G, Froissart M, Janus N, et al. Inappropriate druguse and mortality in community-dwelling elderly with impairedkidney function: The Three-City population-basedstudy. Nephrol Dial Transplant 2011;26:2852-2859.
23. Levey AS, Stevens LA, Schmid CH, et al. A new equationto estimate glomerular filtration rate. Ann Intern Med2009;150:604-612.
24. American Psychiatric Association. Diagnostic and StatisticalManual of Mental Disorders: DSM-IV. Washington,DC: American Psychiatric Association; 1994.
25. McKhann G, Drachman D, Folstein M, Katzman R, PriceD, Stadlan E. Clinical diagnosis of Alzheimer's disease: Reportof the NINCDS-ADRDA work group under the auspicesof Department of Health and Human Services TaskForce on Alzheimer's disease. Neurology 1984;34:939-944. (Pubitemid 14076461)
26. Roman G, Tatemichi T, Erkinjuntti T, et al. Vascular dementia:diagnostic criteria for research studies: Report ofthe NINDS-AIREN International Workshop. Neurology1993;43:250-260. (Pubitemid 23060253)
27. Yaffe K, Ackerson L, Kurella Tamura M, et al. Chronickidney disease and cognitive function in older adults: Findingsfrom the chronic renal insufficiency cohort cognitivestudy. J Am Geriatr Soc 2010;58:338-345.
28. Kurella Tamura M, Xie D, Yaffe K, et al. Vascular riskfactors and cognitive impairment in chronic kidney disease:The Chronic Renal Insufficiency Cohort (CRIC)study. Clin J Am Soc Nephrol 2011;6:248-256.
29. Weiner DE, Bartolomei K, Scott T, et al. Albuminuria,cognitive functioning, and white matter hyperintensities inhomebound elders. Am J Kidney Dis 2009;53:438-447.
30. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY.Chronic kidney disease and the risks of death, cardiovascularevents, and hospitalization. N Engl J Med 2004;351:1296-1305.
31. Stengel B, Metzger M, Froissart M, et al. Epidemiologyand prognosis of chronic kidney disease in the elderly: TheThree-City prospective cohort study. Nephrol Dial TransplantEpub 2011 Jun 15.
32. Commenges D, Joly P, Letenneur L, Dartigues JF. Incidenceand mortality of Alzheimer's disease or dementiausing an illness-death model. Stat Med 2004;23:199-210. (Pubitemid 38100634)
33. K/DOQI clinical practice guidelines for chronic kidneydisease: Evaluation, classification, and stratification. Am JKidney Dis 2002;39(2 suppl 1):S1-S266.
34. Knopman DS. Cerebrovascular disease and dementia. Br JRadiol 2007;80(spec 2):S121-S127. (Pubitemid 351799339)
35. Carmichael O, Schwarz C, Drucker D, et al. Longitudinalchanges in white matter disease and cognition in the firstyear of the Alzheimer disease neuroimaging initiative. ArchNeurol 2010;67:1370-1378.
36. Ikram MA, Vernooij MW, Hofman A, Niessen WJ,van der Lugt A, Breteler MM. Kidney function is relatedto cerebral small vessel disease. Stroke 2008;39:55-61.
37. Khatri M, Wright CB, Nickolas TL, et al. Chronic kidneydisease is associated with white matter hyperintensity volume:The Northern Manhattan Study (NOMAS). Stroke2007;38:3121-3126. (Pubitemid 350175724)
38. Knopman DS, Mosley TH Jr, Bailey KR, Jack CR Jr,Schwartz GL, Turner ST. Associations of microalbuminuriawith brain atrophy and white matter hyperintensitiesin hypertensive sibships. J Neurol Sci 2008;271:53-60.
39. Wada M, Nagasawa H, Kurita K, et al. Microalbuminuriais a risk factor for cerebral small vessel disease incommunity-based elderly subjects. J Neurol Sci 2007;255:27-34. (Pubitemid 46414018)
40. Kuo HK, Lin LY, Yu YH. Microalbuminuria is a negativecorrelate for cognitive function in older adults with peripheralarterial disease: Results from the U.S. National Healthand Nutrition Examination Survey 1999-2002. J InternMed 2007;262:562-570.